Eliane Gouvêa de Oliveira Barros

ORCID: 0000-0002-0020-6653 · 4 papers in corpus · active 2015-2022

Study types

  • article 3
  • preprint 1

Condition tags

  • endometriosis 4
  • mesh:D004715 2
article 2022
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph15111414

Background: Current drugs for the treatment of endometriosis are not able to completely cure the condition, and significant side effects hinder the continuation of treatment. Therefore, it is necessary to search for new drug candidates. In …

preprint 2022
·doi:10.20944/preprints202210.0219.v1

Background: Current drug for the treatment of endometriosis is not able of completely cure and significant side effects hinder the continuation of treatment. So, the search for new drug candidates is necessary, and the use of plants extract…

article 2016
Histology and histopathology ·doi:10.14670/hh-11-730

Endometriosis is a benign gynecological disease affecting approximately 10-15% of women of reproductive age and 25-50% of all infertile women. It is characterized by the presence of glands and/or endometrial stroma outside the uterine cavit…

article 2015
The Journal of pharmacy and pharmacology ·doi:10.1111/jphp.12479

OBJECTIVES: The hormonal treatment for endometriosis frequently fails to completely eradicate endometriotic implants. A new therapeutic treatment is needed. This study investigates the in-vitro effect of Copaifera langsdorffii oil-resin on …